Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation

Minimal residual disease (MRD) monitoring has proven to be one of the fundamental independent prognostic factors for patients with acute lymphoblastic leukemia (ALL). Sequential monitoring of MRD using sensitive and specific methods, such as real-time quantitative polymerase chain reaction (qPCR) or...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, In-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386891/
https://www.ncbi.nlm.nih.gov/pubmed/32719172
http://dx.doi.org/10.5045/br.2020.S004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386891/
https://www.ncbi.nlm.nih.gov/pubmed/32719172
http://dx.doi.org/10.5045/br.2020.S004

Ejemplares similares